COLL - Collegium Pharmaceutical EPS misses by $0.14 misses on revenue November, 04 2021 04:43 PM Collegium Pharmaceutical Inc. Collegium Pharmaceutical (NASDAQ:COLL): Q3 GAAP EPS of $0.22 misses by $0.14. Revenue of $78.84M (-0.4% Y/Y) misses by $5.81M. Press Release For further details see: Collegium Pharmaceutical EPS misses by $0.14, misses on revenue